{"transactions":[{"id":772169,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:43:07.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":89,"price":167.943,"value":14946.927,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":28664,"source":{"system":"sec-edgar","filing":"0001781480-26-000008","document":"wk-form4_1779241385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000178148026000008/wk-form4_1779241385.xml","form_type":"4"}},{"id":940101,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-14T01:19:50.000Z","date":"2026-01-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":885,"price":275.74,"value":244029.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":28530,"source":{"system":"sec-edgar","filing":"0001781480-26-000006","document":"wk-form4_1768353587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000178148026000006/wk-form4_1768353587.xml","form_type":"4"}},{"id":941082,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T22:50:29.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":7700,"derivative":{"exercise_price":294.38,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001689548-26-000013","document":"wk-form4_1768258226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000168954826000013/wk-form4_1768258226.xml","form_type":"4"}},{"id":941081,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:50:29.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1087,"price":288.45,"value":313545.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":29415,"source":{"system":"sec-edgar","filing":"0001689548-26-000013","document":"wk-form4_1768258226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000168954826000013/wk-form4_1768258226.xml","form_type":"4"}},{"id":941080,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:50:29.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":9625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Ms. Sniecinski was awarded 9,625 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":30502,"source":{"system":"sec-edgar","filing":"0001689548-26-000013","document":"wk-form4_1768258226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000168954826000013/wk-form4_1768258226.xml","form_type":"4"}},{"id":2941060,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2020-12-17T21:45:24.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":225000,"derivative":{"exercise_price":8.31,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001127602-20-031803","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220031803/form4.xml","form_type":"4"}},{"id":3331857,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2019-12-26T22:13:22.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":240000,"derivative":{"exercise_price":3.23,"exercise_date":"2020-12-17","expiration_date":"2029-12-17","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001127602-19-035852","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219035852/form4a.xml","form_type":"4/A","original_submission_date":"2019-12-19"}},{"id":3335834,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2019-12-19T22:49:56.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":202000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":202000,"derivative":{"exercise_price":3.23,"exercise_date":"2020-12-17","expiration_date":"2029-12-17","underlying":"Common Stock","underlying_shares":202000},"source":{"system":"sec-edgar","filing":"0001127602-19-035549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219035549/form4.xml","form_type":"4"}},{"id":3369160,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-11-18T21:16:18.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":45000,"price":1.45,"value":65250.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001127602-19-033033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219033033/form4.xml","form_type":"4"}},{"id":3469379,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2019-07-03T17:25:29.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Inducement option grant becomes exercisable at the rate of 30% on the first anniversary of the grant date with the remainder vesting in three equal installments on the second, third and fourth anniversaries of the grant date."}],"balance_after":500000,"derivative":{"exercise_price":3.71,"exercise_date":"2020-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001127602-19-023901","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219023901/form4.xml","form_type":"4"}}]}